• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Pfizer CEO Bourla says company ready to execute in a 'pivotal' 2023: report

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 20, 2022 at 11:22: AM
via After Pfizer launched to pandemic superstar status with its BioNTech-partnered COVID-19 vaccine, Comirnaty, the company has something to prove with its next few launches. And next year is setting up to be a pivotal year for the drugmaker, one that could feature up to 10 new launches, CEO Albert Bourla, Ph.D., said in an interview at Yahoo Finance’s All Markets Summit.

article source
 




Top Bottom
Back
Quote